Location History:
- Mobile, AL (US) (2008)
- Brighton, MA (US) (2005 - 2010)
Company Filing History:
5 out of 1,210 
2 out of 389 
1 out of 1,373 
Years Active: 2005-2010
As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can assist you with your request. Here is an article about the inventor Tatyana Chernova:
Title: Unveiling the Innovations of Tatyana Chernova
Introduction:
Tatyana Chernova, a brilliant inventor based in Brighton, MA (US), has made significant strides in the field of biotechnology and immunotherapy. With an impressive portfolio of 5 patents, Chernova's groundbreaking work has revolutionized methods for upregulating immune responses and enhancing diagnostic and treatment approaches.
Latest Patents:
1. Methods for upregulating an immune response with agents that inhibit the interaction between PD-L2 and PD-1: Chernova's invention focuses on isolated nucleic acid molecules that encode novel B7-related molecules, serving as ligands for PD-1. This patent also encompasses antisense nucleic acid molecules, recombinant expression vectors, host cells, and nonhuman transgenic animals. Additionally, the patent includes isolated PD-L2 polypeptides, fusion proteins, antigenic peptides, and anti-PD-L2 antibodies, along with methods for modulating the PD-L2 and PD-1 interaction.
2. B7-4 Antibodies and uses therefor: Chernova's innovative work extends to isolated nucleic acid molecules encoding B7-4 polypeptides. The patent covers antisense nucleic acid molecules, recombinant expression vectors, host cells, nonhuman transgenic animals, isolated B7-4 proteins, fusion proteins, antigenic peptides, and anti-B7-4 antibodies. Diagnostic, screening, and therapeutic methods utilizing these compositions are part of this patent.
Career Highlights:
Throughout his career, Tatyana Chernova has made significant contributions while working at esteemed organizations such as Dana-Farber Cancer Institute Inc. and Genetics Institute, Inc. His relentless pursuit of innovation and commitment to advancing biotechnological solutions have garnered recognition in the scientific community.
Collaborations:
Chernova's collaborative efforts with esteemed coworkers like Nelly Malenkovich and Gordon J Freeman have played a crucial role in shaping his innovative projects. The synergy between these talented individuals has led to the development of groundbreaking technologies that have the potential to transform the field of immunotherapy.
Conclusion:
Tatyana Chernova's inventive prowess and dedication to scientific advancement underscore his position as a trailblazer in the realm of biotechnology. His patents not only highlight his innovative spirit but also signify his commitment to improving diagnostic and treatment methodologies in the world of immunotherapy. Chernova's collaborations and career milestones serve as a testament to his invaluable contributions to the field, paving the way for future breakthroughs in biotechnological innovation.